Macedonian Journal of Medical Sciences
[International, Peer Reviewed]

About MJMS

Our policies

MJMS Online

For contributors

Services

Why publish in MJMS?
Editors
Boards
Indexing
Membership
Evaluation

Editorial & publishing policies
Competing interests policy 
Open access
Open access license

Publication fee
Reviewer guidelines

Online first
Current issue
Journal archive

Online first fact sheet
Free Registration
Contact

Guidelines  [pdf]
Online submission
Help for authors
Cover letter
Reviewers of MJMS

Reviewers Summary

Transliteration
Subscriptions

Advertising
Reprints and permissions
Resources
ICMJE Disclosure Form

 

Macedonian Journal of Medical Sciences. 2012 Mar 15; 5(1):85-89.

http://dx.doi.org/10.3889/MJMS.1957-5773.2011.0211

Clinical Science

 

Efficacy of Zonisamide – Levetiracetam Comedication in Nine Adult Patients with Difficult to Treat Epilepsy and Intellectual Disability (A Case Series Report)
 

Peter Martin and Jörg Fahrbach


Séguin Clinic for Persons with Severe Intellectual Disability, Epilepsy Centre Kork, Landstr 1, D-77694 Kehl-Kork, Germany

 

Abstract

 

 

Aim: Few studies have concerned anticonvulsive combination therapies in epilepsies resistant to established antiepileptic drugs in monotherapy. We sought to delineate the effects of zonisamide – levetiracetam comedication (ZNS+LEV) in adults with intellectual disabilities (ID).

Material and Methods: Nine adult patients with drug resistant epilepsies and ID were treated in a routine outpatient setting with LEV or ZNS in combination with other anticonvulsants first and in a combination of both of them (ZNS+LEV) thereafter. Seizure frequency and behavioural effects were recorded in patients treated who approved to benefit from the combination of both substances but not when treated with only either of them.

Results: The longitudinal follow up of individual cases of patients with difficult to treat epilepsies and intellectual disabilitiy (ID) suggests that the combination of ZNS and LEV may be an effective and well tolerated option, even if LEV or ZNS alone or in either other combinations had failed to reduce seizure frequency.

Conclusions: These findings may not be generalized but request to perform further controlled studies on the efficacy and tolerability of the anticonvulsive therapy of ZNS in combination with LEV.

..................

Citation: Martin P, Fahrbach J. Efficacy of Zonisamide – Levetiracetam Comedication in Nine Adult Patients with Difficult to Treat Epilepsy and Intellectual Disability (A Case Series Report). Maced J Med Sci. 2012 Mar 15; 5(1):78-89. http://dx.doi.org/10.3889/MJMS.1957-5773.2011.0211.
Key words: Anticonvulsants; Combination; Zonisamide and Levetiracetam; Drug resistant epilepsy; Intellectual disability; Case studies.
Correspondence: Peter Martin. Séguin Clinic for Persons with Severe Intellectual Disability, Landstr. 1, D-77694 Kehl-Kork, Germany. Phone: 0049 7851 84 2252. Fax: 0049 7851 84 2602. E-mail: pmartin@epilepsiezentrum.de
Received: 31-Oct-2011; Revised: 24-Nov-2011; Accepted: 25-Nov-2011; Online first: 05-Dec-2011
Copyright: © 2011 Martin P. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing Interests: The authors have declared that no competing interests exist.

 

< Previous | Next Article >

Table of contents

 

This Article (free)

Abstract

Full text (html)

Full text (pdf)

Full text OnlineFirst (pdf)

Citations

- DOAJ

- Index Copernicus

- Socol@r

Google Scholar

- Martin P
- Fahrbach J

PubMed

- Martin P
- Fahrbach J

 


Publication of the MJMS is supported by the Macedonian Ministry of Education and Sciences. Publisher: Institute of Immunobiology and Human GeneticsSkopje, Republic of Macedonia.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

MJMS Print (ISSN 1857-5749) is an international peer-reviewed, Open Access journal published four times per year. MJMS Online (ISSN 1857-5773) offers free access to all articles.


Creative Commons Attribution LicenseAll site content, except where otherwise noted, is licensed under a Creative Commons Attribution License.